Roche and Hansoh Pharma Sign Drug Deal Worth Over $15 Billion

• Roche and China's Hansoh Pharma have entered into a significant drug development partnership.
• The deal is estimated to be worth over $15 billion, according to multiple sources.
• The partnership aims to enhance drug development and market access in China.
• This collaboration could lead to the creation of new cancer treatments.
• The agreement reflects Roche's strategy to expand its presence in the Chinese market.